List of Excipients in API sapropterin dihydrochloride
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing sapropterin dihydrochloride
Detailed excipient profiles for sapropterin dihydrochloride
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
sapropterin dihydrochloride drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | sapropterin dihydrochloride | 49884-720 |
| >Company | >Ingredient | >NDC |
sapropterin dihydrochloride drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Excipient focus: ASCORBIC ACID
sapropterin dihydrochloride drug variants containing ASCORBIC ACID
sapropterin dihydrochloride drug variants not containing ASCORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
sapropterin dihydrochloride drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | sapropterin dihydrochloride | 49884-720 |
| >Company | >Ingredient | >NDC |
sapropterin dihydrochloride drug variants not containing COPOVIDONE K25-31
Excipient focus: CROSPOVIDONE
sapropterin dihydrochloride drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | sapropterin dihydrochloride | 31722-045 |
| Dr Reddys Laboratories Inc | sapropterin dihydrochloride | 43598-096 |
| Par Pharmaceutical Inc | sapropterin dihydrochloride | 49884-720 |
| NorthStar RxLLC | sapropterin dihydrochloride | 72603-191 |
| >Company | >Ingredient | >NDC |
sapropterin dihydrochloride drug variants not containing CROSPOVIDONE
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
sapropterin dihydrochloride drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddys Laboratories Inc | sapropterin dihydrochloride | 43598-096 |
| >Company | >Ingredient | >NDC |
sapropterin dihydrochloride drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Excipient focus: MANNITOL
sapropterin dihydrochloride drug variants containing MANNITOL
sapropterin dihydrochloride drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CITRATE
sapropterin dihydrochloride drug variants containing POTASSIUM CITRATE
sapropterin dihydrochloride drug variants not containing POTASSIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | sapropterin dihydrochloride | 31722-045 |
| Dr Reddys Laboratories Inc | sapropterin dihydrochloride | 43598-096 |
| Par Pharmaceutical Inc | sapropterin dihydrochloride | 49884-720 |
| NorthStar RxLLC | sapropterin dihydrochloride | 72603-191 |
| >Company | >Ingredient | >NDC |
Excipient focus: RIBOFLAVIN
sapropterin dihydrochloride drug variants containing RIBOFLAVIN
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | sapropterin dihydrochloride | 31722-045 |
| Dr Reddys Laboratories Inc | sapropterin dihydrochloride | 43598-096 |
| Par Pharmaceutical Inc | sapropterin dihydrochloride | 49884-720 |
| NorthStar RxLLC | sapropterin dihydrochloride | 72603-191 |
| >Company | >Ingredient | >NDC |
sapropterin dihydrochloride drug variants not containing RIBOFLAVIN
Excipient focus: SILICON DIOXIDE
sapropterin dihydrochloride drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | sapropterin dihydrochloride | 31722-045 |
| Dr Reddys Laboratories Inc | sapropterin dihydrochloride | 43598-096 |
| Par Pharmaceutical Inc | sapropterin dihydrochloride | 49884-720 |
| NorthStar RxLLC | sapropterin dihydrochloride | 72603-191 |
| >Company | >Ingredient | >NDC |
sapropterin dihydrochloride drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM STEARYL FUMARATE
sapropterin dihydrochloride drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | sapropterin dihydrochloride | 31722-045 |
| Dr Reddys Laboratories Inc | sapropterin dihydrochloride | 43598-096 |
| Par Pharmaceutical Inc | sapropterin dihydrochloride | 49884-720 |
| NorthStar RxLLC | sapropterin dihydrochloride | 72603-191 |
| >Company | >Ingredient | >NDC |
sapropterin dihydrochloride drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: SUCRALOSE
sapropterin dihydrochloride drug variants containing SUCRALOSE
sapropterin dihydrochloride drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | sapropterin dihydrochloride | 31722-045 |
| Dr Reddys Laboratories Inc | sapropterin dihydrochloride | 43598-096 |
| Par Pharmaceutical Inc | sapropterin dihydrochloride | 49884-720 |
| NorthStar RxLLC | sapropterin dihydrochloride | 72603-191 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
